Transforming lives with safer, more effective therapies.
Preliminary Population Pharmacokinetics Supports Phase 2 Dose Selection for Masked Anti–PD-L1 Antibody CX-072
Mark Stroh, Michelle Green, B.L. Millard, Will Garner, Hong Lu, Jennifer Richardson, Lawrence Lu, Alison Hannah. Poster presented at the ASCO20 Virtual Scientific Program, May 29-31, 2020.